165 related articles for article (PubMed ID: 32883638)
1. Unraveling the anti-influenza effect of flavonoids: Experimental validation of luteolin and its congeners as potent influenza endonuclease inhibitors.
Zima V; Radilová K; Kožíšek M; Albiñana CB; Karlukova E; Brynda J; Fanfrlík J; Flieger M; Hodek J; Weber J; Majer P; Konvalinka J; Machara A
Eur J Med Chem; 2020 Dec; 208():112754. PubMed ID: 32883638
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and In Vitro Evaluation of C-7 and C-8 Luteolin Derivatives as Influenza Endonuclease Inhibitors.
Reiberger R; Radilová K; Kráľ M; Zima V; Majer P; Brynda J; Dračínský M; Konvalinka J; Kožíšek M; Machara A
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299354
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site.
Yuan P; Bartlam M; Lou Z; Chen S; Zhou J; He X; Lv Z; Ge R; Li X; Deng T; Fodor E; Rao Z; Liu Y
Nature; 2009 Apr; 458(7240):909-13. PubMed ID: 19194458
[TBL] [Abstract][Full Text] [Related]
4. Biochemical characterization of recombinant influenza A polymerase heterotrimer complex: Endonuclease activity and evaluation of inhibitors.
Xing W; Barauskas O; Kirschberg T; Niedziela-Majka A; Clarke M; Birkus G; Weissburg P; Liu X; Schultz BE; Sakowicz R; Kwon H; Feng JY
PLoS One; 2017; 12(8):e0181969. PubMed ID: 28809961
[TBL] [Abstract][Full Text] [Related]
5. The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit.
Dias A; Bouvier D; Crépin T; McCarthy AA; Hart DJ; Baudin F; Cusack S; Ruigrok RW
Nature; 2009 Apr; 458(7240):914-8. PubMed ID: 19194459
[TBL] [Abstract][Full Text] [Related]
6. Structural and biochemical basis for development of influenza virus inhibitors targeting the PA endonuclease.
DuBois RM; Slavish PJ; Baughman BM; Yun MK; Bao J; Webby RJ; Webb TR; White SW
PLoS Pathog; 2012; 8(8):e1002830. PubMed ID: 22876176
[TBL] [Abstract][Full Text] [Related]
7. Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors.
Jones JC; Kumar G; Barman S; Najera I; White SW; Webby RJ; Govorkova EA
mBio; 2018 Apr; 9(2):. PubMed ID: 29691337
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the salicylaldehyde thiosemicarbazone scaffold for inhibition of influenza virus PA endonuclease.
Rogolino D; Bacchi A; De Luca L; Rispoli G; Sechi M; Stevaert A; Naesens L; Carcelli M
J Biol Inorg Chem; 2015 Oct; 20(7):1109-21. PubMed ID: 26323352
[TBL] [Abstract][Full Text] [Related]
9. The active form of the influenza cap-snatching endonuclease inhibitor baloxavir marboxil is a tight binding inhibitor.
Todd B; Tchesnokov EP; Götte M
J Biol Chem; 2021; 296():100486. PubMed ID: 33647314
[TBL] [Abstract][Full Text] [Related]
10. Exploration of the 2,3-dihydroisoindole pharmacophore for inhibition of the influenza virus PA endonuclease.
Rogolino D; Naesens L; Bartoli J; Carcelli M; De Luca L; Pelosi G; Stokes RW; Van Berwaer R; Vittorio S; Stevaert A; Cohen SM
Bioorg Chem; 2021 Nov; 116():105388. PubMed ID: 34670331
[TBL] [Abstract][Full Text] [Related]
11. Structural analysis of specific metal chelating inhibitor binding to the endonuclease domain of influenza pH1N1 (2009) polymerase.
Kowalinski E; Zubieta C; Wolkerstorfer A; Szolar OH; Ruigrok RW; Cusack S
PLoS Pathog; 2012; 8(8):e1002831. PubMed ID: 22876177
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and SARs of dopamine derivatives as potential inhibitors of influenza virus PA
Liao Y; Ye Y; Li S; Zhuang Y; Chen L; Chen J; Cui Z; Huo L; Liu S; Song G
Eur J Med Chem; 2020 Mar; 189():112048. PubMed ID: 31954881
[TBL] [Abstract][Full Text] [Related]
13. Endonuclease substrate selectivity characterized with full-length PA of influenza A virus polymerase.
Noble E; Cox A; Deval J; Kim B
Virology; 2012 Nov; 433(1):27-34. PubMed ID: 22841552
[TBL] [Abstract][Full Text] [Related]
14. N-acylhydrazone inhibitors of influenza virus PA endonuclease with versatile metal binding modes.
Carcelli M; Rogolino D; Gatti A; De Luca L; Sechi M; Kumar G; White SW; Stevaert A; Naesens L
Sci Rep; 2016 Aug; 6():31500. PubMed ID: 27510745
[TBL] [Abstract][Full Text] [Related]
15. Amino acid residues in the N-terminal region of the PA subunit of influenza A virus RNA polymerase play a critical role in protein stability, endonuclease activity, cap binding, and virion RNA promoter binding.
Hara K; Schmidt FI; Crow M; Brownlee GG
J Virol; 2006 Aug; 80(16):7789-98. PubMed ID: 16873236
[TBL] [Abstract][Full Text] [Related]
16. Human cytomegalovirus inhibitor AL18 also possesses activity against influenza A and B viruses.
Muratore G; Mercorelli B; Goracci L; Cruciani G; Digard P; Palù G; Loregian A
Antimicrob Agents Chemother; 2012 Nov; 56(11):6009-13. PubMed ID: 22908168
[TBL] [Abstract][Full Text] [Related]
17. Aryl and Arylalkyl Substituted 3-Hydroxypyridin-2(1H)-ones: Synthesis and Evaluation as Inhibitors of Influenza A Endonuclease.
Sagong HY; Bauman JD; Nogales A; Martínez-Sobrido L; Arnold E; LaVoie EJ
ChemMedChem; 2019 Jun; 14(12):1204-1223. PubMed ID: 30983160
[TBL] [Abstract][Full Text] [Related]
18. Mutational and metal binding analysis of the endonuclease domain of the influenza virus polymerase PA subunit.
Crépin T; Dias A; Palencia A; Swale C; Cusack S; Ruigrok RW
J Virol; 2010 Sep; 84(18):9096-104. PubMed ID: 20592097
[TBL] [Abstract][Full Text] [Related]
19. Identification of influenza endonuclease inhibitors using a novel fluorescence polarization assay.
Baughman BM; Jake Slavish P; DuBois RM; Boyd VA; White SW; Webb TR
ACS Chem Biol; 2012 Mar; 7(3):526-34. PubMed ID: 22211528
[TBL] [Abstract][Full Text] [Related]
20. Structural and Thermodynamic Analysis of the Resistance Development to Pimodivir (VX-787), the Clinical Inhibitor of Cap Binding to PB2 Subunit of Influenza A Polymerase.
Gregor J; Radilová K; Brynda J; Fanfrlík J; Konvalinka J; Kožíšek M
Molecules; 2021 Feb; 26(4):. PubMed ID: 33673017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
